Bortezomib

Nat Rev Drug Discov. 2003 Aug;2(8):611-2. doi: 10.1038/nrd1159.
No abstract available

MeSH terms

  • Antineoplastic Agents* / adverse effects
  • Antineoplastic Agents* / economics
  • Antineoplastic Agents* / therapeutic use
  • Boronic Acids* / adverse effects
  • Boronic Acids* / economics
  • Boronic Acids* / therapeutic use
  • Bortezomib
  • Clinical Trials as Topic
  • Drug Industry / economics*
  • Humans
  • Multiple Myeloma / drug therapy*
  • Protease Inhibitors* / adverse effects
  • Protease Inhibitors* / economics
  • Protease Inhibitors* / therapeutic use
  • Pyrazines* / adverse effects
  • Pyrazines* / economics
  • Pyrazines* / therapeutic use
  • Treatment Outcome
  • United States

Substances

  • Antineoplastic Agents
  • Boronic Acids
  • Protease Inhibitors
  • Pyrazines
  • Bortezomib